| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697599 | Cancer Treatment Reviews | 2017 | 8 Pages |
Abstract
Despite the paucity of data about the molecular drivers associated with GEP-NEC, some alterations may be potentially targeted with new cancer-directed therapies. Collaborative clinical trials for patients with advanced GEP-NEC are urgently needed.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Daniel M. Girardi, Andrea C.B. Silva, Juliana Florinda M. Rêgo, Renata A. Coudry, Rachel P. Riechelmann,